Echorouk Forum: CEO of Algeria's pharmaceutical Saidal set to go beyond 8 billion dollars in 2015

Medecines bill in Algeria will multiply by 5 times from 1.5 billion to $8 billion by 2015, according to CEO of Algerian pharmaceutical company Saidal Rachid Zaaouani.

•  
•  
• Rachid Zaaouani sounded Monday told Echorouk Saidal recorded 28 new medicines in the first semester of 2008 and 100 other new medicines will be reached in 2008. “That allowed increasing the number of new medicines developed by the company to 120 in 2 years.”
•  
•  
•  
•  
• We will produce 100 medicines with prices less than 400 percent of their imported ones
•  
• Saidal’s CEO said his group is about to get over with the first phase of its current strategy. Positive results have been achieved and it will be reinforced by the second phase due to start next year. More than 100 medicines for chronic diseases are expected to be produced with competitive prices less than imported medicines by 400 percent.
•  
• Rachid Zaaouani indicated that Saidal’s plan aims at producing and developing medicines which represent 80 percent of Algerian medicines market. Productions of medicines which do not exist in the country are also included in the plan.
•  
•  
• Saidal gained 4 calls for tender to export medicines to Senegal
•  
• Zaaouani said the pharmaceutical company gained 4 calls for tender to export medicines to Senegal in addition to 17 medicines recorded in Burkina Faso.
• “In 2007, Saidal exported 22 million Algerian dinars of medicines with most of them to Senegal, Libya, Burkina Faso, Congo, Chad, Yemen and Niger.”
• According to him, the company found difficulties to record its products in the Middle East due to complications. “That will push Saidal to conclude agreements to solve this problem.”
• He added that his group is going to invest in Latin America and the exports value will reach 5 billion DA in 2015.
•  
•  
•  
• Rachid Zaaouani…a long expertise in the service of Saidal
•  
• Rachid Zaaouani studied in Pharmacy University in Algiers in the 1980’s. He is an expert in pharmacy industry in the Arab World and Africa. He entered Saidal in 1987 as a chemist specialised in production. Three years later, he was appointed as a director of medicines production. In 2000, he held the position of a director of sales. In 2003, he was appointed as a director of partnership and industrial development. His competence and long experience made him eligible to be appointed as a chief executive official of Saidal, a month ago.
•  
•  
• Figures
•  
•  
• Medecines reimbursement reached 65 billion Algerian dinars in 2007.
• 3,000 employees at Saidal.
• 10 medicines laboratories employ 3,000 biologists.
• 80 percent of medicines consumed by old people.